Russia praises the effectiveness of the Sputnik V vaccine, but the West is skeptical of such statements

Russia’s Health Ministry issued a statement on Monday, November 9, saying that the country’s vaccine against the new coronavirus Sputnik V is more than 90 percent effective. Officials are relying on data obtained from vaccinating humans, not on ongoing clinical trials.

Pfizer Inc. and BioNTech, vaccine developers, said Monday that the effectiveness of their experimental vaccine exceeds 90 percent.

“We are responsible for monitoring the effectiveness of the Sputnik V vaccine, which is already being vaccinated in the country as part of a mass vaccination. Based on the observations, we can say that the efficacy of the vaccine is greater than 90%. “Another effective vaccine is good news for everyone,” said Oksana Drapkina, director of the research institute at the Russian Ministry of Health.

Although the latest phase of clinical trials is not yet complete, Russia has ruled that the domestically developed vaccine is safe, even though the vaccine is viewed with considerable skepticism outside of Russia.

Preliminary results from a large-scale human clinical trial called Phase III are currently awaited and expected in November. In Moscow, the vaccine is being tested with 40 thousand. volunteers.